As global markets navigate the challenges posed by rising U.S. Treasury yields and tepid economic growth, investors are increasingly focused on identifying opportunities within a fluctuating landscape. Amid these conditions, stocks that are estimated to be trading below their intrinsic value offer potential for those looking to capitalize on market inefficiencies.
Name | Current Price | Fair Value (Est) | Discount (Est) |
Lindab International (OM:LIAB) | SEK227.40 | SEK453.69 | 49.9% |
California Resources (NYSE:CRC) | US$52.09 | US$104.09 | 50% |
Geovis TechnologyLtd (SHSE:688568) | CN¥40.77 | CN¥81.12 | 49.7% |
Grupo Traxión. de (BMV:TRAXION A) | MX$21.46 | MX$42.66 | 49.7% |
Super Group (JSE:SPG) | ZAR23.21 | ZAR46.16 | 49.7% |
WEX (NYSE:WEX) | US$173.16 | US$346.09 | 50% |
Foxtons Group (LSE:FOXT) | £0.594 | £1.19 | 49.9% |
SBI Sumishin Net Bank (TSE:7163) | ¥2725.00 | ¥5408.67 | 49.6% |
DPC Dash (SEHK:1405) | HK$65.00 | HK$129.82 | 49.9% |
Sinch (OM:SINCH) | SEK31.33 | SEK62.49 | 49.9% |
Click here to see the full list of 939 stocks from our Undervalued Stocks Based On Cash Flows screener.
Let's uncover some gems from our specialized screener.
Overview: Vimian Group AB (publ) operates in the global animal health industry and has a market cap of SEK23.70 billion.
Operations: The company's revenue is derived from four main segments: Medtech (€112.75 million), Diagnostics (€20.32 million), Specialty Pharma (€163.45 million), and Veterinary Services (€56.11 million).
Estimated Discount To Fair Value: 19.1%
Vimian Group is trading at SEK45.3, below its estimated fair value of SEK55.97, suggesting it may be undervalued based on cash flows. Despite recent net losses in Q3 2024, the company has shown strong revenue growth and forecasts significant earnings growth of 94.1% annually over the next three years, outpacing the Swedish market's 15.8%. However, past shareholder dilution and low future return on equity (9.1%) are potential concerns for investors.
Overview: Kotobuki Spirits Co., Ltd. is a Japanese company that produces and sells sweets, with a market capitalization of approximately ¥319.07 billion.
Operations: The company's revenue segments include Shukrei at ¥27.03 billion, Casey Shii at ¥18.88 billion, Kujukushima at ¥6.56 billion, Sales Subsidiaries at ¥7.06 billion, and Kotobuki Confectionery/Tajima Kotobuki at ¥13.19 billion.
Estimated Discount To Fair Value: 39%
Kotobuki Spirits, trading at ¥2095.5, is significantly undervalued with a fair value estimate of ¥3434.73. The company's earnings grew by 33.7% last year and are forecast to grow 12.8% annually, surpassing the JP market's growth rate of 8.7%. Despite revenue growth being slower than 20% per year, its projected return on equity is robust at 28.1%, making it an attractive proposition for investors focused on cash flow valuation metrics.
Overview: Trend Micro Incorporated is a company that develops and sells security-related software for computers and related services both in Japan and internationally, with a market cap of ¥1.06 trillion.
Operations: The company's revenue segments are distributed as follows: ¥84.17 billion from Japan, ¥63.59 billion from Europe, ¥70.46 billion from the Americas, and ¥126.28 billion from the Asia Pacific region.
Estimated Discount To Fair Value: 37.3%
Trend Micro, priced at ¥8157, is trading significantly below its fair value estimate of ¥13013.24, highlighting potential undervaluation based on cash flows. Despite a dip in profit margins from 11.2% to 6.4%, earnings are set to grow at 21.52% annually, outpacing the JP market's 8.7%. Recent innovations like Trend Micro Check and strategic partnerships underscore its commitment to AI-driven cybersecurity solutions amidst acquisition interest due to stock underperformance and yen depreciation.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include OM:VIMIAN TSE:2222 and TSE:4704.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.